These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22282960)

  • 1. Utility of methyl 2-isothiocyanatobenzoate in the synthesis of some new quinazoline derivatives as potential anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Bayomi AA
    Arzneimittelforschung; 2011; 61(12):719-26. PubMed ID: 22282960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of some new pyrazole and pyrimidine derivatives carrying a sulfonamide moiety of expected antitumor activity and study of the synergistic effect of gamma-irradiation.
    Ghorab MM; Ragab FA; Heiba HI; Youssef HA; Galal M
    Arzneimittelforschung; 2010; 60(1):48-55. PubMed ID: 20184227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety.
    Ghorab MM; Shaaban MA; Refaat HM; Heiba HI; Ibrahim SS
    Eur J Med Chem; 2012 Jul; 53():403-7. PubMed ID: 22583778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
    Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; El-Gazzar MG
    Arzneimittelforschung; 2012 Jan; 62(1):46-52. PubMed ID: 22331763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of γ-radiation.
    Ghorab MM; Ragab FA; Heiba HI; Nissan YM; Ghorab WM
    Arch Pharm Res; 2012 Aug; 35(8):1335-46. PubMed ID: 22941476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives.
    El-Said MS; El-Gazzar MG; Al-Dosari MS; Ghorab MM
    Arzneimittelforschung; 2012 Mar; 62(3):149-56. PubMed ID: 22270843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pyrazole derivatives as anticancer and radiosensitizing agents.
    Aly HM; El-Gazzar MG
    Arzneimittelforschung; 2012 Mar; 62(3):105-12. PubMed ID: 22407898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; El-Hazek RM
    Eur J Med Chem; 2011 Oct; 46(10):5120-6. PubMed ID: 21890248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
    Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and docking studies of some novel quinoline derivatives bearing a sulfonamide moiety as possible anticancer agents.
    Ghorab MM; Ragab FA; Hamed MM
    Arzneimittelforschung; 2010; 60(3):141-8. PubMed ID: 20422946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity.
    Bashandy MS; Al-Said MS; Al-Qasoumi SI; Ghorab MM
    Arzneimittelforschung; 2011; 61(9):521-6. PubMed ID: 22029229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cytotoxicity of 2-phenylquinazolin-4(3H)-one derivatives.
    Rhee HK; Yoo JH; Lee E; Kwon YJ; Seo HR; Lee YS; Choo HY
    Eur J Med Chem; 2011 Sep; 46(9):3900-8. PubMed ID: 21704436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs.
    Khalil AA; Abdel-Hamide SG; Al-Obaid AM; El-Subbagh HI
    Arch Pharm (Weinheim); 2003 Apr; 336(2):95-103. PubMed ID: 12761762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of some novel 4-Chloro-N-(4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Soliman AM
    Eur J Med Chem; 2016 Jul; 117():8-18. PubMed ID: 27085944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
    Papadopoulou MV; Bloomer WD
    Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
    Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
    Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
    Alafeefy AM; Ashour AE
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.